{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:55Z","timestamp":1760060155099,"version":"build-2065373602"},"reference-count":54,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Department of Obstetrics &amp; Gynecology at the University of Iowa, USA"},{"name":"the American Association of Obstetricians and Gynecologists Foundation (AAOGF) Bridge Funding Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>High-grade serous ovarian cancer (HGSC) is a heterogeneous disease. RNA sequencing (RNAseq) of bulk solid tissue is of limited use in these populations due to heterogeneity. Single-cell RNA-seq (scRNA-seq) allows for the identification of diverse genetic compositions of heterogeneous cell populations. New computational methodologies are now available that use scRNAseq results to estimate cell type proportions in bulk RNAseq data. We performed bulk RNA-seq gene expression analysis on 112 HGSC specimens and 12 benign fallopian tube (FT) controls. We identified several publicly available scRNAseq datasets for use as annotation and reference datasets. Deconvolution was performed with MUlti-Subject SIngle Cell Deconvolution (MuSiC) to estimate cell type proportions in the bulk RNA-seq data. Datasets from the Cancer Genome Atlas (TCGA). HGSC repositories were also evaluated. Clinical variables and percentages of cell types were compared for differences in clinical outcomes and treatment results. Pathway enrichment analysis was also performed. Different annotations for referenced scRNA-seq datasets used for deconvolution of bulk RNA-seq data revealed different cellular proportions that were significantly associated with clinical outcomes; for example, higher proportions of macrophages were associated with a better response to primary chemotherapy. Our deconvolution study of bulk RNAseq HGSC samples identified cell populations within the tumor that may be associated with some of the observed clinical outcomes.<\/jats:p>","DOI":"10.3390\/ijms26157512","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T07:45:11Z","timestamp":1754466311000},"page":"7512","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["scRNA-seq Can Identify Different Cell Populations in Ovarian Cancer Bulk RNA-seq Experiments"],"prefix":"10.3390","volume":"26","author":[{"given":"Sofia","family":"Gabrilovich","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7131-8604","authenticated-orcid":false,"given":"Eric","family":"Devor","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Dr., Iowa City, IA 52242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Cardillo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jefferson Health, 3941 Commerce Ave, Willow Grove, PA 19090, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bender","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Dr., Iowa City, IA 52242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Goodheart","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Dr., Iowa City, IA 52242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-4528","authenticated-orcid":false,"given":"Jesus","family":"Gonzalez-Bosquet","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Dr., Iowa City, IA 52242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Schwarz, R.F., Ng, C.K.Y., Cooke, S.L., Newman, S., Temple, J., Piskorz, A.M., Gale, D., Sayal, K., Murtaza, M., and Baldwin, P.J. (2015). Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis. PLoS Med., 12.","DOI":"10.1371\/journal.pmed.1001789"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated Genomic Analyses of Ovarian Carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer","volume":"381","author":"Pautier","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gonzalez Bosquet, J., Devor, E.J., Newtson, A.M., Smith, B.J., Bender, D.P., Goodheart, M.J., McDonald, M.E., Braun, T.A., Thiel, K.W., and Leslie, K.K. (2021). Creation and Validation of Models to Predict Response to Primary Treatment in Serous Ovarian Cancer. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-85256-9"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7150\/jca.49406","article-title":"Current Ovarian Cancer Maintenance Strategies and Promising New Developments","volume":"12","author":"Gogineni","year":"2021","journal-title":"J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-016-0548-9","article-title":"Prediction of Chemo-Response in Serous Ovarian Cancer","volume":"15","author":"Newtson","year":"2016","journal-title":"Mol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/GRF.0000000000000516","article-title":"Characterization of a TP53 Somatic Variant of Unknown Function From an Ovarian Cancer Patient Using Organoid Culture and Computational Modeling","volume":"63","author":"Bi","year":"2020","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GRF.0000000000000493","article-title":"Prediction of Epithelial Ovarian Cancer Outcomes With Integration of Genomic Data","volume":"63","author":"Newtson","year":"2020","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1158\/0008-5472.CAN-14-0186","article-title":"Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data","volume":"74","author":"Bosquet","year":"2014","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_12","first-page":"517","article-title":"Prognostically Relevant Gene Signatures of High-Grade Serous Ovarian Carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"dju249","DOI":"10.1093\/jnci\/dju249","article-title":"Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer","volume":"106","author":"Konecny","year":"2014","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-18-0784","article-title":"Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma","volume":"24","author":"Chen","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41467-018-08023-x","article-title":"Bulk Tissue Cell Type Deconvolution with Multi-Subject Single-Cell Expression Reference","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1038\/s41467-020-19015-1","article-title":"Benchmarking of Cell Type Deconvolution Pipelines for Transcriptomics Data","volume":"11","author":"Powell","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tube","volume":"8","author":"Papp","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular Analysis of High-Grade Serous Ovarian Carcinoma with and without Associated Serous Tubal Intra-Epithelial Carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Liang, L., Yu, J., Li, J., Li, N., Liu, J., Xiu, L., Zeng, J., Wang, T., and Wu, L. (2021). Integration of ScRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.711020"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and Pharmacological Modulators of the Tumor Immune Contexture Revealed by Deconvolution of RNA-Seq Data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","article-title":"High-Grade Serous Tubo-Ovarian Cancer Refined with Single-Cell RNA Sequencing: Specific Cell Subtypes Influence Survival and Determine Molecular Subtype Classification","volume":"13","author":"Olbrecht","year":"2021","journal-title":"Genome Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Greppi, M., Tabellini, G., Patrizi, O., Candiani, S., Decensi, A., Parolini, S., Sivori, S., Pesce, S., Paleari, L., and Marcenaro, E. (2019). Strengthening the Antitumor NK Cell Function for the Treatment of Ovarian Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040890"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mabbott, N.A., Baillie, J.K., Brown, H., Freeman, T.C., and Hume, D.A. (2013). An Expression Atlas of Human Primary Cells: Inference of Gene Function from Coexpression Networks. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-632"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1158\/0008-5472.CAN-21-3819","article-title":"Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhao, B., and Pei, L. (2023). A Macrophage Related Signature for Predicting Prognosis and Drug Sensitivity in Ovarian Cancer Based on Integrative Machine Learning. BMC Med. Genom., 16.","DOI":"10.1186\/s12920-023-01671-z"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"154739","DOI":"10.1016\/j.prp.2023.154739","article-title":"Tumor-Associated Macrophages: Potential Therapeutic Targets and Diagnostic Markers in Cancer","volume":"249","author":"Song","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejca.2015.12.016","article-title":"Targeting the Tumour Microenvironment in Ovarian Cancer","volume":"56","author":"Hansen","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International Validation of the Consensus Immunoscore for the Classification of Colon Cancer: A Prognostic and Accuracy Study","volume":"391","author":"Mlecnik","year":"2018","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mezheyeuski, A., Backman, M., Mattsson, J., Mart\u00edn-Bernab\u00e9, A., Larsson, C., Hrynchyk, I., Hammarstr\u00f6m, K., Str\u00f6m, S., Ekstr\u00f6m, J., and Mauchanski, S. (2023). An Immune Score Reflecting Pro- and Anti-Tumoural Balance of Tumour Microenvironment Has Major Prognostic Impact and Predicts Immunotherapy Response in Solid Cancers. EBioMedicine, 88.","DOI":"10.1016\/j.ebiom.2023.104452"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110849","DOI":"10.1016\/j.cellsig.2023.110849","article-title":"Pharmacological Inhibition of Protein Kinase D Suppresses Epithelial Ovarian Cancer via MAPK\/ERK1\/2\/Runx2 Signalling Axis","volume":"110","author":"Tyagi","year":"2023","journal-title":"Cell. Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.taap.2014.08.019","article-title":"Keratinocyte-Derived IL-24 Plays a Role in the Positive Feedback Regulation of Epidermal Inflammation in Response to Environmental and Endogenous Toxic Stressors","volume":"280","author":"Jin","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12272-014-0383-8","article-title":"Cantharidin Inhibits Angiogenesis by Suppressing VEGF-Induced JAK1\/STAT3, ERK and AKT Signaling Pathways","volume":"38","author":"Wang","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/JCMA.0000000000000258","article-title":"Longxuetongluo Capsule Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulating Multiple Signaling Pathways in BV2 Microglia Cells","volume":"83","author":"Hong","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/21691401.2019.1573189","article-title":"Notoginsenoside R1 Promotes MC3T3-E1 Differentiation by up-Regulating MiR-23a via MAPK and JAK1\/STAT3 Pathways","volume":"47","author":"Wang","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1158\/1535-7163.MCT-14-0077","article-title":"Targeting JAK1\/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer","volume":"13","author":"Wen","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"24304","DOI":"10.18632\/oncotarget.24368","article-title":"Ruxolitinib Synergistically Enhances the Anti-Tumor Activity of Paclitaxel in Human Ovarian Cancer","volume":"9","author":"Han","year":"2018","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hippen, A.A., Omran, D.K., Weber, L.M., Jung, E., Drapkin, R., Doherty, J.A., Hicks, S.C., and Greene, C.S. (2023). Performance of Computational Algorithms to Deconvolve Heterogeneous Bulk Ovarian Tumor Tissue Depends on Experimental Factors. Genome Biol., 24.","DOI":"10.1186\/s13059-023-03077-7"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From Bulk, Single-Cell to Spatial RNA Sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int. J. Oral Sci."},{"key":"ref_43","unstructured":"(2024, November 24). U.S. Census Bureau QuickFacts: Lowa, Available online: https:\/\/www.census.gov\/quickfacts\/IA."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccell.2020.01.003","article-title":"The Repertoire of Serous Ovarian Cancer Non-Genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells","volume":"37","author":"Hu","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.2147\/CMAR.S202628","article-title":"An Integrated Prediction Model of Recurrence in Endometrial Endometrioid Cancers","volume":"11","author":"Miller","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread Aligner: Fast, Accurate and Scalable Read Mapping by Seed-and-Vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: An Efficient General Purpose Program for Assigning Sequence Reads to Genomic Features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Love, M.I., Huber, W., and Anders, S. (2014). Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2. Genome Biol., 15.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-Based Analysis of Lung Single-Cell Sequencing Reveals a Transitional Profibrotic Macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary Learning for Integrative, Multimodal and Scalable Single-Cell Analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.C., and M\u00fcller, M. (2011). PROC: An Open-Source Package for R and S+ to Analyze and Compare ROC Curves. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-77"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The SVA Package for Removing Batch Effects and Other Unwanted Variation in High-Throughput Experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"D258","DOI":"10.1093\/nar\/gkh036","article-title":"The Gene Oncology (GO) Database and Informatics Resource","volume":"32","author":"Harris","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_54","unstructured":"R Core Team (2019). R: A Language and Environment for Statistical Computing, R Foundation Statistics and Computing. version 4.3.1."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7512\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:22:35Z","timestamp":1760034155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":54,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157512"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157512","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,8,4]]}}}